Published in Cancer Weekly, October 7th, 2008
"Combination of AAV-HGFK1 and Ad-p53 significantly prolonged the survival of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.